1. Left Ventricular Dysfunction Global Clinical Trials Review, H2,
2012
Report Details:
Published:November 2012
No. of Pages: 97
Price: Single User License – US$2500
Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2012
Summary
GlobalData''s clinical trial report, “Left Ventricular Dysfunction Global Clinical Trials Review, H2,
2012" provides data on the Left Ventricular Dysfunction clinical trial scenario. This report provides
elemental information and data relating to the clinical trials on Left Ventricular Dysfunction. It
includes an overview of the trial numbers and their recruitment status as per the site of trial
conduction across the globe. The databook offers a preliminary coverage of disease clinical trials
by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the
number of trials for the key drugs for treating Left Ventricular Dysfunction. This report is built using
data and information sourced from proprietary databases, primary and secondary research and in-
house analysis by GlobalData''s team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and
relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America,
Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along
with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and
sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner

2. - Abridged view of the performance of the trials in terms of their status, recruitment, location,
sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Get your copy of this report @
http://www.reportsnreports.com/reports/210606-left-ventricular-dysfunction-global-clinical-trials-review-h2-
2012.html
Major points covered in Table of Contents of this report include
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Left Ventricular Dysfunction 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Left Ventricular Dysfunction 24
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Left Ventricular Dysfunction Therapeutics Clinical Trials 29
Prominent Drug Comparison 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Amgen Inc. 32
Clinical Trial Overview of Amgen Inc. 32
Bayer AG 33
Clinical Trial Overview of Bayer AG 33

3. Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
AstraZeneca PLC 35
Clinical Trial Overview of AstraZeneca PLC 35
ASKLEPIOS proresearch Klinische Forschung und Entwicklung 36
Clinical Trial Overview of ASKLEPIOS proresearch Klinische Forschung und Entwicklung 36
Solvotrin Innovations Ltd 37
Clinical Trial Overview of Solvotrin Innovations Ltd 37
Menarini Laboratories International Operations Luxembourg S.A 38
Clinical Trial Overview of Menarini Laboratories International Operations Luxembourg S.A 38
GlaxoSmithKline LLC 39
Clinical Trial Overview of GlaxoSmithKline LLC 39
ARCA biopharma, Inc. 40
Clinical Trial Overview of ARCA biopharma, Inc. 40
Capricor Inc. 41
Clinical Trial Overview of Capricor Inc. 41
ResMed SAS 42
Clinical Trial Overview of ResMed SAS 42
Medtronic CardioVascular 43
Clinical Trial Overview of Medtronic CardioVascular 43
Cytokinetics, Incorporated 44
Clinical Trial Overview of Cytokinetics, Incorporated 44
Sanofi 45
Clinical Trial Overview of Sanofi 45
Mylan Inc. 46
Clinical Trial Overview of Mylan Inc. 46
Astellas Pharma Inc. 47
Clinical Trial Overview of Astellas Pharma Inc. 47
Acorda Therapeutics, Inc. 48
Clinical Trial Overview of Acorda Therapeutics, Inc. 48
Merck & Co., Inc. 49
Clinical Trial Overview of Merck & Co., Inc. 49
Biotronik SE & Co. KG 50
Clinical Trial Overview of Biotronik SE & Co. KG 50
Medtronic, Inc. 51
Clinical Trial Overview of Medtronic, Inc. 51
Clinical Trial Overview of Top Universities / Institutes / Hospitals 52
University Health Network 52
Clinical Trial Overview of University Health Network 52
University of Ottawa Heart Institute 53
Clinical Trial Overview of University of Ottawa Heart Institute 53
Kyoto University 54

4. Clinical Trial Overview of Kyoto University 54
Imperial College London 55
Clinical Trial Overview of Imperial College London 55
Kyoto Prefectural University of Medicine 56
Clinical Trial Overview of Kyoto Prefectural University of Medicine 56
Xijing Hospital 57
Clinical Trial Overview of Xijing Hospital 57
VU University Medical Center 58
Clinical Trial Overview of VU University Medical Center 58
Sheba Medical Center 59
Clinical Trial Overview of Sheba Medical Center 59
MetroHealth Medical Center 60
Clinical Trial Overview of MetroHealth Medical Center 60
Weill Cornell Medical College 61
Clinical Trial Overview of Weill Cornell Medical College 61
Emory University 62
Clinical Trial Overview of Emory University 62
Cedars-Sinai Medical Center 63
Clinical Trial Overview of Cedars-Sinai Medical Center 63
University of Miami 64
Clinical Trial Overview of University of Miami 64
Charles University 65
Clinical Trial Overview of Charles University 65
University Hospital Basel 66
Clinical Trial Overview of University Hospital Basel 66
University of Pennsylvania 67
Clinical Trial Overview of University of Pennsylvania 67
RWTH Aachen University 68
Clinical Trial Overview of RWTH Aachen University 68
Washington University School of Medicine 69
Clinical Trial Overview of Washington University School of Medicine 69
Assistance Publique - Hopitaux de Paris 70
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 70
Rabin Medical Center 71
Clinical Trial Overview of Rabin Medical Center 71
Five Key Clinical Profiles 72
Appendix 94
Abbreviations 94
Definitions 94
Research Methodology 95
Secondary Research 96
About GlobalData 96

5. Contact Us 96
Disclaimer 96
Source 97
List of Tables
Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials In Progress by Top
Countries, 2012* 10
Left Ventricular Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
11
Left Ventricular Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Left Ventricular Dysfunction Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
Left Ventricular Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Countries,
2012* 14
Left Ventricular Dysfunction Therapeutics Clinical Trials, Central and South America, Top
Countries, 2012* 15
Left Ventricular Dysfunction Therapeutics Clinical Trials, BRIC Countries, 2012* 16
Left Ventricular Dysfunction Therapeutics Clinical Trials, G7 Countries, 2012* 17
Left Ventricular Dysfunction Therapeutics Market, G7 Countries, Clinical Trials by Trial Status,
2012* 18
Left Ventricular Dysfunction Therapeutics Clinical Trials, E7 Countries, 2012* 19
Left Ventricular Dysfunction Therapeutics Market, E7 Countries, Clinical Trials by Trial Status,
2012* 20
Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials In Progress by Phase
2012* 22
Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Left Ventricular Dysfunction Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 24
Left Ventricular Dysfunction Therapeutics Market, Global, Terminated Clinical Trials, 2012* 25
Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target
Trends, 2006-2011 26
Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28
Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
30
Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Clinical Trials by Prominent
Drugs, 2012* 31
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen
Inc., 2012* 32
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer
AG, 2012* 33
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer

6. Inc., 2012* 34
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by
AstraZeneca PLC, 2012* 35
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by
ASKLEPIOS proresearch Klinische Forschung und Entwicklung, 2012* 36
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Solvotrin
Innovations Ltd, 2012* 37
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Menarini
Laboratories International Operations Luxembourg S.A, 2012* 38
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by
GlaxoSmithKline LLC, 2012* 39
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by ARCA
biopharma, Inc., 2012* 40
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Capricor
Inc., 2012* 41
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by ResMed
SAS, 2012* 42
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by
Medtronic CardioVascular, 2012* 43
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by
Cytokinetics, Incorporated, 2012* 44
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi,
2012* 45
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan
Inc., 2012* 46
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas
Pharma Inc., 2012* 47
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Acorda
Therapeutics, Inc., 2012* 48
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck &
Co., Inc., 2012* 49
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Biotronik
SE & Co. KG, 2012* 50
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by
Medtronic, Inc., 2012* 51
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by
University Health Network, 2012* 52
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by
University of Ottawa Heart Institute, 2012* 53
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto
University, 2012* 54
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial

7. College London, 2012* 55
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto
Prefectural University of Medicine, 2012* 56
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Xijing
Hospital, 2012* 57
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by VU
University Medical Center, 2012* 58
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheba
Medical Center, 2012* 59
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by
MetroHealth Medical Center, 2012* 60
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill
Cornell Medical College, 2012* 61
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory
University, 2012* 62
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-
Sinai Medical Center, 2012* 63
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by
University of Miami, 2012* 64
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Charles
University, 2012* 65
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by
University Hospital Basel, 2012* 66
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by
University of Pennsylvania, 2012* 67
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by RWTH
Aachen University, 2012* 68
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by
Washington University School of Medicine, 2012* 69
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by
Assistance Publique - Hopitaux de Paris, 2012* 70
Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin
Medical Center, 2012* 71
List of Figures
Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials In Progress by Top
Countries, 2012* 10
Left Ventricular Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%),
2012* 11
Left Ventricular Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*

8. 12
Left Ventricular Dysfunction Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
13
Left Ventricular Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Countries
(%), 2012* 14
Left Ventricular Dysfunction Therapeutics Clinical Trials, Central and South America, Top
Countries (%), 2012* 15
Left Ventricular Dysfunction Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
Left Ventricular Dysfunction Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
Left Ventricular Dysfunction Therapeutics Market, G7 Countries, Clinical Trials by Trial Status,
2012* 18
Left Ventricular Dysfunction Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
Left Ventricular Dysfunction Therapeutics Market, E7 Countries, Clinical Trials by Trial Status,
2012* 20
Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials In Progress by Phase,
2012* 22
Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target
Trends, 2006-2011 26
Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 27
Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
29
Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Clinical Trials by Prominent
Drugs, 2012* 31
GlobalData Methodology 95
Contact: sales@reportsandreports.com for more information.